| Name | ARC 239 dihydrochloride hydrate |
|---|---|
| Synonyms | ARC 239 dihydrochloride,2-[2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolindionedihydrochloride |
| Description | ARC 239 is an α2B/C-adrenergic receptor antagonist with pKi of 7.06 and 6.95 for rat kidney α2B and human α2C, respectively. ARC 239 also inhibits 5-HT1A receptor with a Ki of 63.1 nM[1][2]. |
|---|---|
| Related Catalog | |
| Target |
human α2C-adrenoceptor:6.95 (pKi) Alpha-2C adrenergic receptor:7.06 (pKi) 5-HT1A Receptor:63.1 nM (Ki) |
| References |
| Density | 1.167g/cm3 |
|---|---|
| Boiling Point | 595.8ºC at 760 mmHg |
| Molecular Formula | C24H29N3O3 |
| Molecular Weight | 407.51 |
| Flash Point | 314.1ºC |
| Exact Mass | 479.17400 |
| PSA | 53.09000 |
| LogP | 4.32220 |
| Index of Refraction | 1.576 |